Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

BTNL2 helps protect hair follicles from immune attacks.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

IL-27 can prevent hair loss in alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Mitochondrial stress can lead to atopic dermatitis.

ILC1-like cells can cause alopecia areata by themselves.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Certain NK cell changes in blood may indicate alopecia areata progression.

The gut microbiome affects the development of alopecia areata.

Alopecia areata involves unique activation of certain immune cells.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

JAK inhibitors might help treat alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.